Ronit Almog - Epidemiology

Author Information

Ronit Almog is affiliated with the Epidemiology Department and Biobank at Rambam Healthcare Campus in Haifa, Israel, and also with the School of Public Health at the University of Haifa in Haifa, Israel. Her research focuses primarily on epidemiology and public health, with a significant emphasis on infectious diseases, cancer, and immunology.

Research Contributions

Ronit Almog has made substantial contributions to the field of epidemiology and public health. Her research includes the study of community antibiotic prescriptions during the COVID-19 era, the development of SARS-CoV-2 variants, and the immunogenicity of COVID-19 vaccines among healthcare workers. She has also investigated the psychosocial perspectives of cancer patients during the COVID-19 crisis, the characteristics of continuous oximetry measurement in COVID-19 patients, and the impact of vaccines on pediatric community-acquired bacteremia. Her work is highly relevant to current global health challenges and contributes valuable insights into disease prevention and management.

Aliases

Ronit Almog is also known by several other names in academic publications, including R Almog, R. Almog, and Roni Almog.

Publication and Citation Metrics

Metric	Value
Citation Count	2059
H-index	21
Paper Count	95

Publications:

Community antibiotic prescriptions during COVID-19 era: a population-based cohort study among adults

DOI: 10.1016/j.cmi.2022.02.035

Year: 2022

SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection

DOI: 10.1371/journal.ppat.1010242

Year: 2022

The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors

DOI: 10.1038/s41467-021-25664-7

Year: 2021

Psychosocial perspectives among cancer patients during the coronavirus disease 2019 (COVID‐19) crisis: An observational longitudinal study

DOI: 10.1002/cnr2.1506

Year: 2021

Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel

DOI: 10.1016/j.cmi.2021.11.014

Year: 2021

Descriptive characteristics of continuous oximetry measurement in moderate to severe COVID-19 patients

DOI: 10.1101/2021.09.26.21264135

Year: 2021

Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis.

DOI: 10.55563/clinexprheumatol/1sx5yk

Year: 2021

The impact of pneumococcal conjugate vaccine-13 on the incidence of pediatric community-acquired bacteremia.

DOI: 10.1007/s10096-021-04167-9

Year: 2021

Comparing COVID-19 and Influenza Presentation and Trajectory

DOI: 10.3389/fmed.2021.656405

Year: 2021

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer

DOI: 10.1001/jamaoncol.2021.2675

Year: 2021

What Are the Consequences of Losing Trust?

How Can Training and Education Foster Collaboration?

How Does Histopathology Contribute to Epidemiology?

What are Aerosol Particles?

What are the outcomes of EPIET training?

Why is Shielding Important?

What is the Biological Gradient?

Why is Ergonomic Stress Important in Epidemiology?

What are the Major Funding Sources in Epidemiology?

How Are BRCA Mutations Detected?

Partnered Content Networks

Relevant Topics